Literature DB >> 16484628

Rho kinases in cardiovascular physiology and pathophysiology.

Gervaise Loirand1, Patrice Guérin, Pierre Pacaud.   

Abstract

Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have been found to regulate a wide range of fundamental cell functions such as contraction, motility, proliferation, and apoptosis. Abnormal activation of the RhoA/ROCK pathway has been observed in major cardiovascular disorders such as atherosclerosis, restenosis, hypertension, pulmonary hypertension, and cardiac hypertrophy. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of ROCK signaling and its roles in cardiovascular physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484628     DOI: 10.1161/01.RES.0000201960.04223.3c

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  192 in total

Review 1.  Cell signaling of angiotensin II on vascular tone: novel mechanisms.

Authors:  Aurelie Nguyen Dinh Cat; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 2.  The role of Rho protein signaling in hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Nat Rev Cardiol       Date:  2010-08-31       Impact factor: 32.419

3.  Urotensin II alters vascular reactivity in animals subjected to volume overload.

Authors:  Gregory S Harris; Robert M Lust; Laxmansa C Katwa; Christopher J Wingard
Journal:  Peptides       Date:  2010-08-17       Impact factor: 3.750

4.  A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor.

Authors:  Mun Chun Chan; Peter H Nguyen; Brandi N Davis; Nobumichi Ohoka; Hidetoshi Hayashi; Keyong Du; Giorgio Lagna; Akiko Hata
Journal:  Mol Cell Biol       Date:  2007-06-18       Impact factor: 4.272

5.  Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Authors:  Yi-Chu Liao; Ping-Yen Liu; Hsiu-Fen Lin; Wen-Yi Lin; James K Liao; Suh-Hang H Juo
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

Review 6.  Regulation of calcium channels in smooth muscle: new insights into the role of myosin light chain kinase.

Authors:  A Martinsen; C Dessy; N Morel
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

7.  28-Day hindlimb unweighting reduces expression of Rho kinase and inhibits its effects in femoral artery of rat.

Authors:  Zhong-Chao Wang; Huan Liu; Yun-Gang Bai; Jin-Wen Yu; Hai-Jun Zhang; Yao-Ping Cheng; Jun-Xiang Bao; Xin-Ling Ren; Hong-Zhe Ma; Jin Ma
Journal:  J Physiol Biochem       Date:  2015-03-12       Impact factor: 4.158

8.  Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.

Authors:  Asad Zeidan; Xiaohong Tracey Gan; Ashley Thomas; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2013-10-06       Impact factor: 3.396

9.  Novel role for aldose reductase in mediating acute inflammatory responses in the lung.

Authors:  Thyyar M Ravindranath; Phyllus Y Mong; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Ann Marie Schmidt; Ravichandran Ramasamy; Qin Wang
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells.

Authors:  Kayoko Miyata; Ryousuke Satou; Weijian Shao; Minolfa C Prieto; Maki Urushihara; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.